Peter Kadas Overview

  • Primary Position
  • Non-Executive Di...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 1

  • Med. Deal Size

Peter Kadas General Information

Biography

Mr. Peter Kadas served as Non-Executive Director at Marex Spectron. Mr. Peter Kadas serves as Board Member at Treos Bio. Kadas also served as Senior Advisor at BXR Group. He also served as vice-chairman of the board of directors of OKD from 2006 to 2007. He has also served as director of BXR Real Estate Investments B.V. and RPG Property B.V. since 2006 and 2008 respectively. Mr Kadas is a Senior Advisor of BXR Partners LLP, an affiliate of BXR Group. From 2001 until 2010 he was a director of Bakala Crossroads Partners Ltd, also a BXR Group affiliate. Between 1997 and 2001 he was a managing director of Croesus Central Europe and from 1996 to 1997 he worked as a managing director for MC Securities in London. In 1995 he co-founded Renaissance Capital, Russia's first private investment bank. In 1990 he was a Director of Credit Suisse First Boston in Budapest. Mr Kadas also served on numerous corporate boards in the region, including CSFB, the management committee of Renaissance Capital, and vice-chairman of the board of directors of České radiokomunikace. Mr Kadas graduated in 1986 from Trinity College, University of Toronto with a Bachelor of Arts degree in Economics and Politics. In 1990 he obtained a Master of Business Administration degree from Dartmouth College.

Contact Information

Primary Position
Non-Executive Director, Marex Group
Education
Dartmouth College, MBA (Master of Business Administration)
University of Toronto, BA (Bachelor of Arts)
Gender
Male
Email
pk
Phone
+44 020
Address
  • 1st Floor
  • 40-44 Newman Street
  • London W1T 1QD
  • England, United Kingdom
+44 020

Peter Kadas Board Seats (1)

Company Industry Ownership Status Financing Status Location Since
Treos Bio Drug Discovery Privately Held (backing) Venture Capital-Backed London, United Kingdom

Peter Kadas Lead Partner on Deals (1)

Peter Kadas has been the lead partner on 1 deal. Their latest deal was with Treos Bio, a drug discovery company. The deal was made for on 30-Sep-2019.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Treos Bio 30-Sep-2019 Early Stage VC (Series A) Completed Drug Discovery London, United Kingdom

Peter Kadas Network (55)

Board Members (47)

Name Company Representing Location From
Konstantin Schweinitz Marex Group Self London, United Kingdom
Ian Lowitt Marex Group Marex Group London, United Kingdom
Treos Bio Outsized Ventures London, United Kingdom
Marex Group JRJ Group London, United Kingdom
Marex Group Self London, United Kingdom

Portfolio Executives (8)

Name Company Role Deal date Location
Menghis Bairu MD Treos Bio Executive Chairman 30-Sep-2019 London, United Kingdom
Enikő Tőke Ph.D Treos Bio Chief Scientific Officer & Board Member 30-Sep-2019 London, United Kingdom
Treos Bio Chief Financial Officer & Board Member 30-Sep-2019 London, United Kingdom
Treos Bio Chief Medical Officer 30-Sep-2019 London, United Kingdom
Treos Bio Co-Founder & Board Member 30-Sep-2019 London, United Kingdom

Peter Kadas FAQs

  • Who is Peter Kadas?

    Mr. Peter Kadas served as Non-Executive Director at Marex Spectron.

  • How much does Peter Kadas typically invest?

    Peter Kadas's median deal size is .

  • What is Peter Kadas’s main position?

    Peter Kadas’s primary position is Non-Executive Director.

  • What are the contact details for Peter Kadas?

    Peter Kadas’s email address is pk and his phone number is +44 020 .

  • How many active board seats does Peter Kadas hold?

    Peter Kadas holds a board seat in Treos Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »